Fresenius Kabi and Phlow Corp. have announced a collaboration to onshore the manufacture of Epinephrine Injection, USP, a medicine designated as essential by the U.S. Food and Drug Administration and the World Health Organization. The agreement covers domestic production of
“Intrinsically, there is nothing wrong with using Chinese CDMOs. But because of geopolitical issues, some large pharma want to have redundancy of that supply chain in the US.” Dr. Reza Oliyai, President and CEO of Oliyai Consulting Corporation, spent 28
By 2028, SGS CDMO Solutions’ MHRA and FDA-inspected site in Wales will operate entirely without paper. For biotech and Pharmaceutical sponsors, this provides a better way to run development and manufacturing projects. “If it can’t be done digitally, then we
WuXi Biologics said it has received a Platinum Medal from EcoVadis for the third year in a row, marking the highest level of recognition from the sustainability assessment platform. The rating places the company among the top one percent of
Samsung Biologics said its product carbon footprint system has been validated by Det Norske Veritas, an independent third-party assurance provider. The validation confirms that the company’s PCF calculation methodology aligns with globally recognized standards, including ISO 14067 and PAS 2050.
When Lonza announced its partnership with RION in September 2025 to manufacture platelet-derived exosome therapeutics, the collaboration signaled growing CDMO investment in specialized modalities. As exosome-based therapies advance from academic research toward commercial reality, manufacturing scale-up presents distinct technical and
Government portal promises dramatic discounts, but experts question real-world affordability for insured patients The Trump administration launched TrumpRx.gov on Thursday evening, a government-run portal connecting cash-paying patients with pharmaceutical manufacturers offering discounted prescription drugs. The website went live with 43
Scarab Genomics said it has entered into an exclusive licensing partnership with Bionova Scientific, granting Bionova rights to use one of Scarab’s proprietary Clean Genome® E. coli strains for plasmid DNA production. The agreement supports pDNA manufacturing for advanced biologics
Eurofins CDMO Alphora said its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program to support a research and development collaboration focused on next-generation antibody-drug conjugate production. The project aims
The pharma manufacturing landscape in 2026 is more volatile than ever. Take part in this benchmarking study to see how your peers are responding. Rapidly changing geopolitics. Capacity constraints. Pricing pressure. Technology disruption. The challenges facing biopharma sponsors and CDMO
